Page last updated: 2024-11-12

1,4-dihydroxy-2-methoxy-7-methylanthraquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID12416403
CHEMBL ID1224808
SCHEMBL ID23199031
MeSH IDM0498009

Synonyms (6)

Synonym
CHEMBL1224808
austrocortinin
1,4-dihydroxy-3-methoxy-6-methylanthraquinone
SCHEMBL23199031
1,4-dihydroxy-2-methoxy-7-methylanthraquinone
1,4-dihydroxy-2-methoxy-7-methylanthracene-9,10-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID669351Antibacterial activity against Vibrio anguillarum ATCC 19019 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID1176175Cytotoxicity against human HCT116 cells after 72 hrs by cell counting Kit-8 assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The fungal natural product (1S,3S)-austrocortirubin induces DNA damage in HCT116 cells via a mechanism unique from other DNA damaging agents.
AID669347Antibacterial activity against Streptomyces albus ATCC 8799 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID669345Antibacterial activity against Bacillus cereus ACCC 11077 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID669349Antibacterial activity against Micrococcus tetragenus ATCC 13623 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID504295Antimicrobial activity against methicillin-resistant Staphylococcus aureus by colorimetric broth microdilution test2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID669348Antibacterial activity against Staphylococcus aureus ATCC 27154 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID716989Cytotoxicity against human NFF cells after 3 days by sulforhodamine B assay2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold.
AID504300Cytotoxicity against human KB cells2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID716988Selectivity index, ratio of IC50 for human NFF cells to IC50 for chloroquine-sensitive ring stage plasmodium falciparum 3D72012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold.
AID669344Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID669350Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID717115Antimalarial activity against chloroquine-sensitive ring stage plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold.
AID504302Cytotoxicity against african green monkey Vero cells2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID669346Antibacterial activity against Micrococcus luteus ATCC 49732 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID717112Antimalarial activity against chloroquine-resistant ring stage plasmodium falciparum Dd2 infected in erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold.
AID504298Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by microculture radioisotope technique2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID504299Antimycobacterial activity against Mycobacterium tuberculosis H37Ra by green fluorescent protein-based fluorescent assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID1601833Inhibition of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B at 100 uM relative to control2019European journal of medicinal chemistry, Mar-01, Volume: 165Marine natural products as potential anti-tubercular agents.
AID504301Cytotoxicity against human MCF7 cells2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID504294Antimicrobial activity against Staphylococcus aureus by colorimetric broth microdilution test2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Anthraquinone, cyclopentanone, and naphthoquinone derivatives from the sea fan-derived fungi Fusarium spp. PSU-F14 and PSU-F135.
AID669352Antibacterial activity against Vibrio parahaemolyticus ATCC 17802 after 24 hrs by serial dilution technique2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
AID669354Cytotoxicity against human A549 cells by MTT assay2012Journal of natural products, May-25, Volume: 75, Issue:5
Antibacterial anthraquinone derivatives from a sea anemone-derived fungus Nigrospora sp.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]